Transmitter Release From Mammalian Horizontal Cells.

哺乳动物水平细胞释放发射器。

基本信息

项目摘要

DESCRIPTION (provided by applicant): The photoreceptor synaptic triad, consisting of a photoreceptor terminal, bipolar cell dendrites and horizontal cell endings, is a specialized synaptic complex of great importance. Physiologically, this is the site of initial transfer of visual information from photoreceptors and the fidelity of information transfer is critically important for visual processing. Horizontal cells mediate inhibitory feedback in the outer retina at bipolar cell dendrites and photoreceptor terminals; however, the mechanisms that underlie transmitter release from mammalian horizontal cells are poorly understood. For instance, horizontal cell endings in the synaptic triad have relatively few small, clear-core vesicles and they lack conventionally defined presynaptic membrane specializations. In contrast, these cells express established synaptic vesicle proteins, including the vesicular GABA transporter (VGAT) and SV2A, a complement of synaptic proteins, including SNAP-25 and complexin, that are associated with exocytosis, and L-type Ca2+ channels, suggesting GABA is released by a vesicular mechanism. This mechanism differs from a previously established GABA plasmalemmal transporter mechanism described for non-mammalian horizontal cells. The long-term objective of this project is to understand the functional role of mammalian horizontal cells in visual information processing. This application will address this objective by examining the hypothesis that the cellular structure and biochemical machinery that mediate vesicular transmitter release are present in mammalian horizontal cells. This hypothesis will be examined as follows: Specific aim 1: Characterize vesicles in horizontal cell endings in the synaptic triad. Vesicle type, number and distribution in horizontal cell dendrites that innervate cone pedicles and axonal terminals that innervate rod spherules will be examined with conventional electron microscopy. Specific aim 2: Examine the distribution of the principal vesicular proteins which are involved in regulated exocytosis in horizontal cell endings by determining the expression of a) VGAT and b) VAMP isoforms, SV2A, synaptotagmin 1 and 2, Rab3 isoforms, and the vacuolar proton pump with RT-PCR and immunohistochemistry. Specific aim 3: Examine the distribution of key synaptic proteins, which participate in vesicle docking, priming and fusion in regulated transmitter release, in horizontal cell endings by determining the expression of syntaxin, SNAP-25 and complexin 1-4, Munc 13-1 and 18, and RIM1 with RT-PCR and immunohistochemistry. These studies will further elucidate the structural and biochemical basis of transmitter release from horizontal cells, thus providing a better understanding of the functional role of horizontal cells in the outer retina. These findings will aid in the development of therapeutic strategies for the treatment of pathological changes in the outer retina related to retinal disease, such as macular degeneration.
说明(申请人提供):光感受器突触三联体由光感受器终末、双极细胞树突和水平细胞末端组成,是一种特殊的突触复合体,具有重要意义。从生理上讲,这是光感受器最初传递视觉信息的地方,信息传递的保真度对视觉处理至关重要。水平细胞在双极细胞树突和光感受器终末介导视网膜外区域的抑制性反馈;然而,哺乳动物水平细胞释放递质的机制尚不清楚。例如,突触三联体中的水平细胞末端有相对较少的小而清晰的核心小泡,它们缺乏传统上定义的突触前膜特化。相反,这些细胞表达已建立的突触小泡蛋白,包括囊泡型GABA转运体(VGAT)和SV2a,以及与胞吐相关的突触蛋白,包括SNAP-25和Complin,以及L型钙通道,表明GABA是通过囊泡机制释放的。这一机制不同于先前为非哺乳动物水平细胞所描述的GABA质膜转运蛋白机制。 这个项目的长期目标是了解哺乳动物水平细胞在视觉信息处理中的功能作用。这项应用将通过检验哺乳动物水平细胞中存在介导囊泡递质释放的细胞结构和生化机制的假设来解决这一目标。这一假设将被检验如下:具体目标1:描述突触三联体中水平细胞末端的小泡的特征。用常规电子显微镜观察支配锥体蒂的水平细胞树突和支配杆状小球的轴突末梢中的囊泡类型、数量和分布。具体目的2:通过RT-PCR和免疫组织化学方法检测a)VGAT和b)VAMP亚型、SV2A、突触素1和2、Rab3亚型以及空泡质子泵在水平细胞末端参与调节胞吐作用的主要囊泡蛋白的分布。具体目的3:通过RT-PCR和免疫组织化学方法检测Synaxin、SNAP-25和Complin 1-4、MUNC 13-1和18以及RIM1的表达,检测参与囊泡对接、启动和融合的关键突触蛋白在水平细胞终末的分布。 这些研究将进一步阐明水平细胞释放递质的结构和生化基础,从而更好地了解水平细胞在视网膜外部的功能作用。这些发现将有助于开发治疗与黄斑变性等视网膜疾病相关的视网膜外部病变的治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICHOLAS C. BRECHA其他文献

NICHOLAS C. BRECHA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICHOLAS C. BRECHA', 18)}}的其他基金

VRC: Reduction of Vision Loss with Early Interventions After Optic Nerve Injury
VRC:视神经损伤后早期干预可减少视力丧失
  • 批准号:
    10597946
  • 财政年份:
    2022
  • 资助金额:
    $ 35.89万
  • 项目类别:
BLR&D Research Career Scientist Award
BLR
  • 批准号:
    10618251
  • 财政年份:
    2020
  • 资助金额:
    $ 35.89万
  • 项目类别:
BLR&D Research Career Scientist Award
BLR
  • 批准号:
    10451508
  • 财政年份:
    2020
  • 资助金额:
    $ 35.89万
  • 项目类别:
Horizontal cell signaling in the mammalian retina
哺乳动物视网膜中的水平细胞信号传导
  • 批准号:
    10090603
  • 财政年份:
    2019
  • 资助金额:
    $ 35.89万
  • 项目类别:
Horizontal cell signaling in the mammalian retina
哺乳动物视网膜中的水平细胞信号传导
  • 批准号:
    10331735
  • 财政年份:
    2019
  • 资助金额:
    $ 35.89万
  • 项目类别:
Horizontal cell signaling in the mammalian retina
哺乳动物视网膜中的水平细胞信号传导
  • 批准号:
    10547806
  • 财政年份:
    2019
  • 资助金额:
    $ 35.89万
  • 项目类别:
Regulation of Calcium Signaling in Retinal Ganglion Cells after Nerve Injury
神经损伤后视网膜神经节细胞钙信号传导的调节
  • 批准号:
    8278451
  • 财政年份:
    2011
  • 资助金额:
    $ 35.89万
  • 项目类别:
Regulation of Calcium Signaling in Retinal Ganglion Cells after Nerve Injury
神经损伤后视网膜神经节细胞钙信号传导的调节
  • 批准号:
    7930758
  • 财政年份:
    2011
  • 资助金额:
    $ 35.89万
  • 项目类别:
Regulation of Calcium Signaling in Retinal Ganglion Cells after Nerve Injury
神经损伤后视网膜神经节细胞钙信号传导的调节
  • 批准号:
    8397567
  • 财政年份:
    2011
  • 资助金额:
    $ 35.89万
  • 项目类别:
Regulation of Calcium Signaling in Retinal Ganglion Cells after Nerve Injury
神经损伤后视网膜神经节细胞钙信号传导的调节
  • 批准号:
    8696777
  • 财政年份:
    2011
  • 资助金额:
    $ 35.89万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了